Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Medtronic Implantable Cardiac Defibrillator Recall Issued Over Low Energy Output Problems More than two dozen incidents have been reported in connection to the Medtronic implantable cardiac defibrillator recall, including 22 injuries caused by problems with low energy output July 19, 2023 Irvin Jackson Add Your Comments Medtronic has issued a massive recall impacting nearly 350,000 implantable cardiac defibrillators, due to a risk the devices may fail to provide life-saving therapy when needed, due to a low energy output that may result in severe injuries or death. The U.S. Food and Drug Administration (FDA) announced the Medtronic recall on July 18, indicating the implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) may fail to produce enough energy to provide high-voltage therapy when necessary. The recall follows dozens of reports involving injuries sustained after the Medtronic devices failed. The FDA has given the recall a Class I designation, warning health care professionals that consumers face an increased risk of sustaining serious injuries or death with continued use. Similar to pacemakers, ICDs and CRT-Ds are medical devices implanted in a person’s chest by a health care professional, which are intended to monitor the heart’s rhythm and automatically deliver electrical shock treatments in response to a range of life-threatening heart conditions, including arrhythmia, or irregular heartbeat, and heart failure. CRT-Ds differ from other cardiac defibrillators, due to their unique ability to synchronize the pumping of the heart’s chambers for patients who are suffering from heart failure, and assist the heart ventricles in working properly. Medtronic Defibrillator Low Energy Output Problems According to the recall notice, the ICDs and CRT-Ds affected by the recall were manufactured after 2017, using a glassed feedthrough, which may cause inappropriate activation of the Short Circuit protection (SCP) feature. This can lead to low or no energy output when the device tries to use high-voltage therapy to regulate the heart’s rhythm. Medtronic has become aware of at least 28 incidents related to the issue, as well as at least 22 injuries that resulted from the low energy output problems. “A reduced-energy shock, or no shock at all, may fail to correct a life-threatening arrhythmia, which can lead to cardiac arrest, other serious injury, or death,” the recall notice warns. “There are additional risks of harm if a patient with one of these devices needs additional surgical procedures to remove and replace the device.” Stay Up-to-Date About Medtronic MiniMed Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic MiniMed lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Medtronic MiniMed Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic MiniMed lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More The recall impacts approximately 348,616 Medtronic defibrillators distributed from October 13, 2017 until June 9, 2023, and includes the following models: Cobalt XT Cobalt Crome Claria MRI Amplia MRI Compia MRI Viva Brava CRT-Ds Visia AF Visia AF MRI Evera Evera MRI Primo MRI Mirro MRI Medtronic sent an urgent medical device correction letter notifying customers of the issue on May 10, which explained the problems with the devices and provided detailed instructions reprogramming the device’s software. Customers with additional questions or concerns are being asked to contact Medtronic technical services by phone at 1-800-929-4043, or their local Medtronic representative. The FDA encourages consumers and health care professionals to report any adverse reactions or issues experienced while using the medial devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online reporting form. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Defibrilator, Heart Failure, Heart Rhythm, ICD, Medical Device Recall, Medtronic More Medtronic MiniMed Lawsuit Stories Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks October 7, 2024 FDA Issues “Do Not Use” Warning for Recalled Medtronic NIM Endotracheal Tubes July 10, 2024 Medfusion Syringe Pump Recall Issued Over Software Errors March 6, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: today) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Lawsuit Alleges Portable Fire Pit Sold on Amazon.com Caused Flashback Burn Injuries (Posted: 3 days ago) A lack of a flame arrestor, and instructions to use rubbing alcohol, led to a teen suffering severe burns due to a flashback event involving a tabletop fire pit. MORE ABOUT: TABLETOP FIRE PIT LAWSUITWayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (09/05/2025)Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025) Lawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (Posted: 4 days ago) Roblox is facing a lawsuit from a Georgia mother who alleges the platform’s failure to implement adequate child safety measures allowed online predators to groom her young son. MORE ABOUT: ROBLOX LAWSUITRoblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)Roblox Sexual Exploitation Lawsuit Alleges 10 Year Old Girl Coerced Into Sending Explicit Images for Robux (08/25/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: today) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Lawsuit Alleges Portable Fire Pit Sold on Amazon.com Caused Flashback Burn Injuries (Posted: 3 days ago) A lack of a flame arrestor, and instructions to use rubbing alcohol, led to a teen suffering severe burns due to a flashback event involving a tabletop fire pit. MORE ABOUT: TABLETOP FIRE PIT LAWSUITWayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (09/05/2025)Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)
Lawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (Posted: 4 days ago) Roblox is facing a lawsuit from a Georgia mother who alleges the platform’s failure to implement adequate child safety measures allowed online predators to groom her young son. MORE ABOUT: ROBLOX LAWSUITRoblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)Roblox Sexual Exploitation Lawsuit Alleges 10 Year Old Girl Coerced Into Sending Explicit Images for Robux (08/25/2025)